Isomorphic Labs raises $2.1 billion to advance AI-driven drug discovery
Isomorphic Labs raised $2.1B in Series B funding to scale its AI drug design engine, IsoDDE, and move drug candidates into clinical trials.
Showing 1–1 of 1
Isomorphic Labs raised $2.1B in Series B funding to scale its AI drug design engine, IsoDDE, and move drug candidates into clinical trials.